duloxetine hydrochloride has been researched along with Abnormalities, Drug-Induced in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, JT; Ankarfeldt, MZ; Fast, T; Hede, SM; Jimenez-Solem, E; Li, H; Motsko, SP; Petersen, J | 1 |
| Bateman, BT; Bessette, LG; Hernandez-Diaz, S; Huybrechts, KF; Levin, R; Li, H; Mogun, H; Motsko, S; Pawar, A; Scantamburlo Fernandes, MF; Upadhyaya, HP | 1 |
| Bellantuono, C; Mandarelli, G; Martini, MG; Nardi, B; Vargas, M | 1 |
| Damkier, P; Ennis, ZN; Lassen, D | 1 |
| Diav-Citrin, O; Einarson, A; Einarson, TR; Kennedy, D; Koren, G; Malm, H; Panchaud, A; Pistelli, A; Smart, K; Stephens, S; Taylor, T; Vial, T; Yates, L | 1 |
2 review(s) available for duloxetine hydrochloride and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
Topics: Abnormalities, Drug-Induced; Breast Feeding; Duloxetine Hydrochloride; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Pregnancy Complications; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2015 |
First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
Topics: Abnormalities, Drug-Induced; Cohort Studies; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2016 |
3 other study(ies) available for duloxetine hydrochloride and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Cohort Studies; Congenital Abnormalities; Denmark; Duloxetine Hydrochloride; Female; Humans; Maternal Exposure; Middle Aged; Pregnancy; Risk Factors; Stillbirth; Sweden; Young Adult | 2021 |
Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Cohort Studies; Duloxetine Hydrochloride; Female; Heart Defects, Congenital; Humans; Infant, Small for Gestational Age; Middle Aged; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prenatal Exposure Delayed Effects; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Young Adult | 2020 |
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Case-Control Studies; Cohort Studies; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Trimesters; Prospective Studies; Sample Size; Thiophenes | 2012 |